| Current Price | $6.54 | Mkt Cap | $35.8M |
|---|---|---|---|
| Open | $6.43 | P/E Ratio | -1.17 |
| Prev. Close | $6.43 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.43 - $6.84 | Volume | 75,446 |
| 52-Wk Range | $1.26 - $15.27 | Avg. Daily Vol. | 187,971 |
| Current Price | $6.54 | Mkt Cap | $35.8M |
|---|---|---|---|
| Open | $6.43 | P/E Ratio | -1.17 |
| Prev. Close | $6.43 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $6.43 - $6.84 | Volume | 75,446 |
| 52-Wk Range | $1.26 - $15.27 | Avg. Daily Vol. | 187,971 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about NERV.
Recs
Bigsef77
(51.07)
Submitted: 5/17/2018 4:24:01 PM :
Start Price:
$54.00
NASDAQ:NERV Score:
-145.10
Minerva Neurosciences shares rise 5% on trial results for schizophrenia drug
,MarketWatch•May 17, 2018
Minerva Neurosciences Inc. shares rose 5.4% in premarket trade on Thursday after results from a phase 2b trial for a schizophrenia drug were published in the peer-reviewed The Journal of Clinical Psychiatry. Patients on the therapy, roluperidone, showed cognitive improvements; the cognitive improvements were also connected to previously-reported improvements in negative symptoms, the company said. Minerva shares have surged 19.3% over the last three months, compared with a 0.4% decline in the S&P 500 and a 1.8% drop in the Dow Jones Industrial Average .
Recs
rbitrage
(82.50)
Submitted: 11/4/2014 4:39:50 PM :
Start Price:
$34.64
NASDAQ:NERV Score:
+192.31
NO earnings. Currently healthcare is overly expensive and growth cannot be sustained. This small stock likely wil go to zero.
Find the members with the highest scoring picks in NERV.
GoldMiner20 (< 20) Score: +257.90
The Score Leader is the player with the highest score across all their picks in NERV.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GoldMiner20 | < 20 | 1/10/2023 |
|
5Y | $1.69 | +294.66% | +10.54% | +284.12 | 0 Comment | |
| GrapeFool | 23.00 | 5/26/2016 |
|
5Y | $76.55 | -91.31% | +104.55% | +195.86 | 0 Comment | |
| rbitrage | 82.50 | 11/6/2014 |
|
5Y | $34.64 | -80.80% | +111.51% | +192.31 | 1 Comment | |
| RafaelStock | 96.58 | 8/1/2016 |
|
5Y | $88.64 | -92.50% | +97.09% | +189.59 | 0 Comment | |
| WildShaman | 77.77 | 7/9/2018 |
|
5Y | $69.20 | -90.39% | +54.79% | +145.18 | 0 Comment | |
| PandaTears | < 20 | 7/26/2021 |
|
5Y | $16.00 | -58.44% | -2.56% | -55.88 | 0 Comment | |
| drugtrader | 58.19 | 11/11/2020 |
|
5Y | $28.20 | -76.42% | +19.80% | -96.22 | 0 Comment | |
| ttkam20 | < 20 | 7/17/2020 |
|
5Y | $28.48 | -76.65% | +33.00% | -109.65 | 0 Comment | |
| stax292007 | 30.49 | 6/1/2020 |
|
5Y | $40.00 | -83.38% | +40.96% | -124.33 | 0 Comment | |
| portefeuille2 | 98.79 | 4/29/2019 |
|
5Y | $58.32 | -88.60% | +45.84% | -134.44 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
